MASS-FIX may allow identification of patients at risk for light chain amyloidosis before the onset of symptoms.
Taxiarchis V KourelisDavid L MurraySurendra DasariSanjay KumarDavid BarnidgeBenjamin MaddenBonnie ArendtPaolo MilaniGiampaolo MerliniMarina Ramirez-AlvaradoRobert A KyleAngela DispenzieriPublished in: American journal of hematology (2018)